Masabumi Shibuya

发表

A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.

Herman Yeger, David Malkin, M. Shibuya, 2005, Cancer research.

KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties.

Yasunari Fujiwara, Nicolas Guilbaud, M. Shibuya, 2006, Cancer research.

The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase

Hiroyuki Aburatani, Shizuo Akira, H. Aburatani, 2008, Nature Cell Biology.

Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family

Zena Wilson, M. Shibuya, S. Barry, 2011, Molecular Cancer Therapeutics.

Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors.

Gerhard Christofori, Eveline Faes-van't Hull, Julien Laurent, 2011, Cancer research.

Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase–Deficient Mice

Kenji Sunagawa, Miho Miyagawa, Tetsuya Matoba, 2009, Arteriosclerosis, thrombosis, and vascular biology.

VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

M. Shibuya, H. Ueno, Tomoko Takahashi, 1999, Oncogene.

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Christoph Dehio, Danica Stanimirovic, Lieve Moons, 2003, Nature Medicine.

Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids

Jeffrey D. Goldsmith, P. Oettgen, M. Shibuya, 2003, Current Biology.

Corneal avascularity is due to soluble VEGF receptor-1

J. Martin Collinson, Eiji Sakurai, Tushar Suthar, 2006, Nature.

A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model

Yoshiko Kobayashi, M. Shibuya, T. Yoneda, 2006, Molecular Cancer Therapeutics.

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.

Lena Claesson-Welsh, M. Shibuya, Masabumi Shibuya, 2006, Experimental cell research.

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.

M. Shibuya, Masabumi Shibuya, 2013, Journal of biochemistry.

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

Antonio Duarte, Gerhard Christofori, Seppo Ylä-Herttuala, 2008, Nature.

Flt-1 signaling in macrophages promotes glioma growth in vivo.

Fabian Kiessling, Matthias Heil, Johannes Waltenberger, 2008, Cancer research.

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.

M. Shibuya, Masabumi Shibuya, Hiroyuki Takahashi, 2005, Clinical science.

Locating inositol 1,4,5-trisphosphate in the nucleus and neuronal dendrites with genetically encoded fluorescent indicators.

Yoshio Umezawa, Moritoshi Sato, M. Shibuya, 2005, Analytical chemistry.

Membrane Fixation of Vascular Endothelial Growth Factor Receptor 1 Ligand-Binding Domain Is Important for Vasculogenesis and Angiogenesis in Mice

Kenji Nakamura, M. Katsuki, M. Shibuya, 2005, Molecular and Cellular Biology.